Page 22 - Cautionary Note News Today

(1)  Assumes a transfer pricing at Matawinie mineral project FS 43-101 operating cost plus transportation cost to Bécancour (2)  Assumes a transfer pricing at Matawinie mineral project FS 43-101 sales price plus transportation cost to Bécancour The Capex and Opex prepared for this FEL-1 are based on a Class 4 type estimate as per the American Association of Cost Engineers (“AACE”) International Practice 18R-97 with a target accuracy between -30% to +40%. The Capex is es...

French Nouveau Monde’s mission and strategy is to become the Western World’s largest producer of high-quality anode materials to be used mainly in batteries for electrical vehicles and renewable energy storage Its large-scale lithium-ion active anode material facility in Bécancour, Québec (Canada) (“Bécancour VAP project”) is an integral part of its strategy Nouveau Monde has acquired a 200,000 m 2 parcel in the industrial park of Bécancour, adjacent to its Phase 1 plant located wit...

Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update - Phase 1 AUGMENT-101 data expected in late 1Q21 or early 2Q21; Phase 2 expansion cohorts expected to commence in 2Q21 - - Enrollment underway in pivotal Phase 2 AGAVE-201 trial of axatilimab in cGVHD - - End of year cash balance of $293.1 million provides cash runway into 2023- - Company to host conference call today at 4:30 p.m. ET - News provided by Share this article Share this art...

Gran Tierra Energy Inc. Announces Fourth Quarter and Year-End Results for 2020 and Operational Update Realized 100% 1P and 133% PDP Reserves Replacement, with $2.65 and $5.06/BOE F&D Costs Achieved 2020 Production of 22,624 bopd Forecast 2021 Production of 28,000-30,000 bopd for Annual Growth of 24-33% Reduced Annual Operating and G&A Costs by $92 Million Achieved Companys Best Safety Year in 2020: Zero Lost Time Incident Frequency CALGARY, Alberta, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Gran Tie...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA™ Mateon Therapeutics, Inc.February 16, 2021 GMT AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) --  Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborat...

Nouveau Monde Announces the Successful Closing of the Previously Announced C$5.75 Million Private Placement Offering The private placement forms part of the previously announced financing, which included a bought deal public offering of C$17 million which was completed in January The net proceeds raised by the Company following these two financings is close to C$22 million Investissement Québec, acting as mandatary for the government of Québec, and Pallinghurst show strong ongoing support, su...

Further advancement of its business plan, strong market conditions and continued confidence and support from The Pallinghurst Group, its largest investor, have enabled Nouveau Monde Graphite Inc. to secure $16.5M from the exercise of previously-issued warrants. As of today, management is of the view that the Company is sufficiently funded for this year’s further development of its mining and value-added projects … Further advancement of its business plan, strong market conditions and contin...

Added 8.3 MMBOE of 1P Reserves Realized 1P Finding and Development Costs of $2.65/boe 1P and 2P Net Asset Value per Share Before Tax of $1.15 and $3.25 1P Reserves Equal 59% of 2P Reserves, Demonstrating Strength of Company’s Proved Reserves Base Achieved Company’s Best Safety Year in 2020: Zero Lost Time Incident Frequency CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“ Gran Tierra” or the “ Company“) (NYSE American:GTE) (TSX:GTE) (LSE: GTE), a com...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 ... Mateon Therapeutics, Inc.January 13, 2021 GMT AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating A...

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC Mateon Therapeutics, Inc. ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda TM against COVID-19. “These interim resul...